Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
出版年份 2011 全文链接
标题
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
作者
关键词
-
出版物
MALARIA JOURNAL
Volume 10, Issue 1, Pages 263
出版商
Springer Nature
发表日期
2011-09-14
DOI
10.1186/1475-2875-10-263
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria
- (2011) Carrie A Morris et al. MALARIA JOURNAL
- Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC
- (2011) Marie A Onyamboko et al. MALARIA JOURNAL
- Intravenous Artesunate for the Treatment of Severe Malaria
- (2010) Karl M Hess et al. ANNALS OF PHARMACOTHERAPY
- New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine
- (2010) S. Krudsood et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT®) following oral administration in African malaria patients
- (2010) V. Sinou et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Pharmacokinetic Profiles of Artesunate After Single Intravenous Doses at 0.5, 1, 2, 4, and 8 mg/kg in Healthy Volunteers: A Phase I Study
- (2009) Qigui Li et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda
- (2009) J. Mwesigwa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Endoperoxide Antimalarials
- (2009) Anirudh Gautam et al. CURRENT DRUG METABOLISM
- Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria
- (2009) Ann K. Miller et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers
- (2009) Visweswaran Navaratnam et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
- (2009) Beesan Tan et al. MALARIA JOURNAL
- Pharmacokinetics, tissue distribution and mass balance of radiolabeled dihydroartemisinin in male rats
- (2009) Lisa H Xie et al. MALARIA JOURNAL
- Population pharmacokinetics of artesunate and amodiaquine in African children
- (2009) Kasia Stepniewska et al. MALARIA JOURNAL
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
- (2008) Catherine Orrell et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration
- (2008) L. T. Diem Thuy et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies
- (2008) N. Lindegardh et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon
- (2008) Michael Ramharter et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started